1-204149896-C-T

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2

The NM_018208.4(ETNK2):​c.325G>A​(p.Val109Met) variant causes a missense change. The variant allele was found at a frequency of 0.000019 in 1,579,046 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000020 ( 0 hom. )

Consequence

ETNK2
NM_018208.4 missense

Scores

1
11
7

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.51
Variant links:
Genes affected
ETNK2 (HGNC:25575): (ethanolamine kinase 2) The protein encoded by this gene is a member of choline/ethanolamine kinase family which catalyzes the first step of phosphatidylethanolamine (PtdEtn) biosynthesis via the cytidine diphosphate (CDP) ethanolamine pathway. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ETNK2NM_018208.4 linkc.325G>A p.Val109Met missense_variant Exon 2 of 8 ENST00000367202.9 NP_060678.2 Q9NVF9-1A0A024R9A8
ETNK2NM_001297760.2 linkc.325G>A p.Val109Met missense_variant Exon 2 of 8 NP_001284689.1 Q9NVF9-2A0A024R976
ETNK2NM_001297762.2 linkc.325G>A p.Val109Met missense_variant Exon 2 of 7 NP_001284691.1 Q9NVF9-3
ETNK2NM_001297761.2 linkc.-17+1699G>A intron_variant Intron 1 of 6 NP_001284690.1 Q9NVF9B7Z1G7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ETNK2ENST00000367202.9 linkc.325G>A p.Val109Met missense_variant Exon 2 of 8 1 NM_018208.4 ENSP00000356170.4 Q9NVF9-1
ETNK2ENST00000367201.7 linkc.325G>A p.Val109Met missense_variant Exon 2 of 8 2 ENSP00000356169.3 Q9NVF9-2
ETNK2ENST00000429525.1 linkc.13G>A p.Val5Met missense_variant Exon 3 of 3 4 ENSP00000394618.1 B7ZC35
ETNK2ENST00000444817.1 linkc.-15G>A upstream_gene_variant 5 ENSP00000406241.1 Q5SXX7

Frequencies

GnomAD3 genomes
AF:
0.00000659
AC:
1
AN:
151840
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000309
AC:
6
AN:
194356
Hom.:
0
AF XY:
0.0000192
AC XY:
2
AN XY:
104012
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000106
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000402
Gnomad FIN exome
AF:
0.0000554
Gnomad NFE exome
AF:
0.0000120
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000203
AC:
29
AN:
1427206
Hom.:
0
Cov.:
35
AF XY:
0.0000113
AC XY:
8
AN XY:
706670
show subpopulations
Gnomad4 AFR exome
AF:
0.0000307
Gnomad4 AMR exome
AF:
0.0000757
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000267
Gnomad4 SAS exome
AF:
0.0000123
Gnomad4 FIN exome
AF:
0.0000392
Gnomad4 NFE exome
AF:
0.0000174
Gnomad4 OTH exome
AF:
0.0000338
GnomAD4 genome
AF:
0.00000659
AC:
1
AN:
151840
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
74142
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000283
Hom.:
0
Bravo
AF:
0.0000227
ExAC
AF:
0.0000166
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jan 01, 2025
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.325G>A (p.V109M) alteration is located in exon 2 (coding exon 2) of the ETNK2 gene. This alteration results from a G to A substitution at nucleotide position 325, causing the valine (V) at amino acid position 109 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.51
BayesDel_addAF
Benign
-0.12
T
BayesDel_noAF
Benign
-0.19
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.27
.;T;.
Eigen
Uncertain
0.59
Eigen_PC
Uncertain
0.56
FATHMM_MKL
Benign
0.71
D
LIST_S2
Uncertain
0.89
D;D;.
M_CAP
Benign
0.028
D
MetaRNN
Uncertain
0.67
D;D;D
MetaSVM
Uncertain
0.10
D
MutationAssessor
Pathogenic
3.0
M;M;.
PrimateAI
Uncertain
0.58
T
PROVEAN
Benign
-2.4
N;N;D
REVEL
Uncertain
0.45
Sift
Uncertain
0.021
D;D;.
Sift4G
Uncertain
0.0020
D;D;.
Polyphen
0.62
P;D;.
Vest4
0.40
MutPred
0.74
Loss of sheet (P = 0.1398);Loss of sheet (P = 0.1398);.;
MVP
0.57
MPC
0.52
ClinPred
0.72
D
GERP RS
4.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.49
gMVP
0.79

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs746164408; hg19: chr1-204119024; API